EAST AURORA, NY–(Marketwire – April 08, 2011) – Moog Inc. (NYSE: MOG.A) (NYSE: MOG.B) announced today that the Food and Drug Administration (FDA) has classified the voluntary correction of the Curlin 6000 CMS, Curlin 6000 CMS IOD, PainSmart, and PainSmart IOD as a Class I recall. The affected models were manufactured and updated from May 2007 to February 2011. The decision to conduct the device recall is due to a software anomaly which leads to software Error Code 45 (EC45), resulting in a shutdown of the pump. This failure may result in a delay or interruption of therapy, which could result in serious injury and\/or death. To date there have been no adverse patient events reported to the Company.<\/p>\n","protected":false},"excerpt":{"rendered":"
EAST AURORA, NY–(Marketwire – April 08, 2011) – Moog Inc. (NYSE: MOG.A) (NYSE: MOG.B) announced today that the Food and Drug Administration (FDA) has classified the voluntary correction of the Curlin 6000 CMS, Curlin 6000 CMS IOD, PainSmart, and PainSmart IOD as a Class I recall. The affected models were manufactured and updated from May … Continue reading Moog Recalls Curlin Ambulatory Infusion Pump Models 6000 CMS, 6000 CMS IOD, PainSmart, and PainSmart IOD<\/span>